Provided by Tiger Trade Technology Pte. Ltd.

CMS

15.440
+0.3001.98%
Volume:2.68M
Turnover:41.21M
Market Cap:37.67B
PE:23.14
High:15.500
Open:15.140
Low:15.140
Close:15.140
52wk High:15.630
52wk Low:6.649
Shares:2.44B
HK Float Shares:2.44B
Volume Ratio:1.23
T/O Rate:0.11%
Dividend:0.31
Dividend Rate:2.01%
EPS(LYR):0.667
ROE:9.91%
ROA:5.58%
PB:1.95
PE(LYR):23.14
PS:4.22

Loading ...

AI Drug Discovery Push And New Kidney Drug Trial Could Be A Game Changer For China Medical System Holdings (SEHK:867)

Simply Wall St.
·
Feb 18

Assessing China Medical System Holdings (SEHK:867) Valuation After New Kidney Trial Approval And AI Drug Discovery Deal

Simply Wall St.
·
Feb 16

China Medical System Expands AI Drug Pipeline As Valuation Gap Persists

Simply Wall St.
·
Feb 13

China Medical System Holdings Limited Announces Exclusive Distribution Agreement for Lidoderm® Lidocaine Cataplasms

Bulletin Express
·
Feb 12

CMS Secures Exclusive Distribution Rights for Lidoderm® Lidocaine Gel Patch

Stock News
·
Feb 12

China Medical System Signs Exclusive Distribution Agreement for Lidoderm Lidocaine Cataplasms

Reuters
·
Feb 12

China Medical System Holdings - Signing of Exclusive Distribution Agreement for Lidoderm Lidocaine Cataplasms

THOMSON REUTERS
·
Feb 12

Small Nucleic Acids Reshape Weight Loss Paradigm with INHBE and ALK7 Targets Showing Initial Validation

Stock News
·
Feb 12

BUZZ-InSilico hits fresh high on partnership deal with China Medical

Reuters
·
Feb 10

Insilico Medicine Enters Drug Development Partnership With China Medical System

MT Newswires Live
·
Feb 10

Insilico Partners with CMS on Multi-Million-Dollar AI-Driven Drug Development for CNS and Autoimmune Disorders

Stock News
·
Feb 10

Insilico Medicine Cayman Topco startet Milliarden-Kooperation mit CMS zur Entwicklung von Medikamenten für das zentrale Nervensystem und Autoimmunerkrankungen

Reuters
·
Feb 10

Assessing China Medical System Holdings (SEHK:867) Valuation After CMS D017 Clinical Trial Approval

Simply Wall St.
·
Feb 05

China Medical System Receives Regulatory Nod to Begin Trials of CMS-D017

MT Newswires Live
·
Feb 04

CMS (00867) Self-Developed Innovative Drug CMS-D017 Capsule Receives Clinical Trial Approval Notice for Complement-Mediated Kidney Diseases

Stock News
·
Feb 03

China Medical System Holdings Limited Approval of Drug Clinical Trials for Cmkd Indication of Innovative Drug CMS-D017

THOMSON REUTERS
·
Feb 03

China Medical System Holdings erhält Zulassung für klinische Studie mit CMS-D017 in China

Reuters
·
Feb 03

China Medical System Holdings - CMS-D017 Capsules Receive Clinical Trial Approval From Nmpa

THOMSON REUTERS
·
Feb 03

CMS (00867) Announces January 2026 Monthly Return with No Share Capital Changes

Bulletin Express
·
Feb 02

Hong Kong Stocks Movement | CMS (00867) Rises Over 3% as Institutions Note Ruxolitinib Cream's Domestic Approval Could Fill the Gap in Vitiligo Targeted Therapy

Stock News
·
Feb 02